Comparison of Continuing Olanzapine to Switching to Quetiapine in Overweight or Obese Patients With Schizophrenia and Schizoaffective Disorder
Clinical trial NCT00090012 · COMPLETED
Trial details
- NCT number
- NCT00090012
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2004-07-01
- Enrollment
- 340
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.